伊姆佩拉 - - 皮肤穿透式微轴流左心室辅助器件的当前问题和未来预期
Shunsuke Saito1, Shohei Okubo1, Taiki Matsuoka1
1Department of Cardiac and Vascular Surgery, Dokkyo Medical University, Mibu, Japan.
Journal of cardiology
|November 5, 2023
概括
临时机械循环支持装置Impella通过改善血液流动和器官 perfusion 帮助急性心力衰竭和心脏性休克. 需要进一步的随机对照试验来确定这种左心室辅助装置 (LVAD) 的最佳使用.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 机械循环支持 机械循环支持
背景情况:
- 暂时的机械循环支持对于急性心力衰竭与心脏性休克至关重要.
- 基于导管的轴流左心室辅助装置 (LVAD) Impella 正因其在血液动力学支持中的作用而引起人们的注意.
- 它独特的设计和功能提供了与传统LVAD相似的好处.
研究的目的:
- 审查Impella支持的原则,生理学,指示和并发症.
- 讨论目前的证据和对Impella设备的未来预期.
- 突出了强大的随机对照试验 (RCT) 的需要.
主要方法:
- 本综述综合了现有文献,包括案例报告和回顾性研究.
- 它研究了Impella对血液动力学和器官 perfusion 的生理影响.
- 该审查讨论了临床指标和潜在的并发症.
主要成果:
- 恩佩拉可以提高平均动脉压和全身血流,改善器官 perfusion 和帮助恢复.
- 它卸载左心室,增加冠状动脉 perfusion 和减少心肌氧需求,促进心脏恢复.
- 在体外膜氧化 (ECMO) 环境中,Impella 作为左心室的机械通风口.
结论:
- 恩佩拉适用于心脏性休克,高风险干预,以及作为恢复,耐用设备或移植的桥梁.
- 高风险心脏手术中的预防性使用正在出现.
- 虽然有希望,来自大型RCT的证据有限但持续,对于定义最佳Impella利用至关重要.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
